Results 241 to 250 of about 370,325 (328)

Theorizing causality: A qualitative study of xylazine‐related wound diversity and perceived etiology among people who inject drugs

Addiction, EarlyView.
Abstract Background and aims Incidence and severity of opioid‐associated skin and soft‐tissue infections, often requiring intensive and costly medical care, have increased substantially since the emergence of xylazine in the US drug supply. Although progress has been made in clinical and harm reduction recommendations for treating xylazine‐related ...
Danielle German, Kelci Villarroel, Meredith Denney, Adrian Guta, Julie Evans, Jason Bienert, Alex Fidler, Kim Ashburn, Zach Kosinski, Becky L. Genberg   +9 more
wiley   +1 more source

Guttate Psoriasis Triggered by Streptococcal Pharyngitis in Older Patients: A Case Report. [PDF]

Am J Case Rep
Thomas DE, Gunasekharan A, Yallapragada RK.   +2 more
europepmc   +1 more source

Long‐Term Efficacy and Safety of Ligelizumab as Re‐Treatment in Patients With Chronic Spontaneous Urticaria

Allergy, EarlyView.
Ligelizumab re‐treatment in CSU patients showed sustained efficacy and tolerability. Over 50% achieved symptom control (UAS7 ≤ 6) by Week 12; benefits maintained through Week 52. No new safety signals observed; aligns with prior PEARL trial outcomes. CSU, chronic spontaneous urticaria; mg, milligram; q4w, every 4 weeks; UAS, urticaria activity score ...
Ana M. Gimenez‐Arnau, Marcus Maurer, Adam Reich, Chia‐Yu Chu, Diana Deleanu, Gordon Sussman, Jorge Sanchez, Knut Brockow, Koremasa Hayama, Michihiro Hide, Mohamed Denguezli, Raisa Meshkova, Roberta F. J. Criado, Sarbjit Saini, Solange Valle, Eva Hua, Pengpeng Wang, Alis Burciu, Isabelle Indermuehle, Vineeth Varanasi, Yolandi Joubert, Thomas Severin, Manmath Patekar   +22 more
wiley   +1 more source

Topical treatments for chronic plaque psoriasis. [PDF]

Cochrane Database Syst Rev
Le Cleach L, Afach S, Veroniki AA, Berens D, Boisvert-Huneault C, Boyle R, Chu DK, Fahim C, Guelimi R, Mason J, Salmi F, Savinova I, Sbidian E, Seeburruth D, Seguin K, Sidre C, Steriopoulos J, Tadrous M, Tarafdar N, Bednar ED, Drucker AM, Cochrane Skin.   +21 more
europepmc   +1 more source

Update on Non‐Biological and RNA‐Based Therapeutics in Chronic Inflammatory Diseases: Precision Medicine Through Small Molecules: An EAACI Position Paper

Allergy, EarlyView.
ABSTRACT In the last decades, critical advancements in research technology and knowledge on disease mechanisms steered therapeutic approaches for chronic inflammatory diseases towards unprecedented target specificity. For allergic and chronic lung diseases, biologic drugs pioneered this goal, acquiring on the way—through the clinical use of monoclonal ...
F. Roth‐Walter, I. M. Adcock, C. Benito‐Villalvilla, R. Bianchini, L. Bjermer, G. Caramori, L. Cari, K. F. Chung, Z. Diamant, I. Eguiluz‐Gracia, E. F. Knol, M. Jesenak, F. Levi‐Schaffer, G. Nocentini, L. O'Mahony, O. Palomares, F. Redegeld, M. Sokolowska, B. Van Esch, M. Zurlo, C. Stellato   +20 more
wiley   +1 more source

The Impact of Tobacco Smoking on Treatment Response Among Patients With Psoriasis Undergoing Biologic Treatment: Prospective Observational Study.

JMIR Hum Factors
Shen F, Ding Y, Zhang X, Xu Q, Duan Z, Cai R, Zhang R, Gao X, Wang R.   +8 more
europepmc   +1 more source

Psoriasis: microbiome dysbiosis and pathogenic mechanisms. [PDF]

Front Immunol
Wang B, Zhang Y, Lin L, Wang S, Yang S.
europepmc   +1 more source

Psoriasis Arthropathica [PDF]

Proceedings of the Royal Society of Medicine, 1931
openaire   +4 more sources

Linear psoriasis and Koebner phenomenon: A review. [PDF]

J Res Med Sci
Zheng L, Han X, Zheng H, Zhang Y.
europepmc   +1 more source